MarketPeel
Insider Trading Intelligence
Pricing
…
BL

Benjamin Landry

HCAT
GENERAL COUNSEL · HEALTH CATALYST, INC. · CIK 0001975281
FILING MIX · LIFETIME24%/76%
BUYS
8
SELLS
25
TOTAL VALUE
$838.8K
COMPANIES
1
ACTIVE SINCE
May 2023
HOLDINGS NOW
364,539
AVG SELL PX
$4.52
TRADE KIND
SHOWING 33 / 33
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 9 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Benjamin Landry, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+81.82%-2.96%+0.45%-3.40%-4.79%—
14d11+81.82%-6.54%+1.09%-7.63%-8.87%—
30d11+81.82%-8.79%+0.97%-9.77%-12.19%—
60d11+72.73%-11.71%+1.46%-13.18%-11.90%—
90d11+72.73%-16.16%+2.52%-18.69%-24.17%—
180d11+81.82%-26.68%+9.66%-34.31%-45.38%—
1y11(2 pending)+100.00%-52.72%+19.41%-72.14%-73.74%—
2y11(7 pending)+100.00%-72.58%+43.50%-113.88%-111.03%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HCAT · 364,539 shares · as of Jun 1, 2026
0101,368202,737304,105405,473202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 25 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
13,779$1.37$18.9K364,539Jun 1, 2026Jun 3, 2026 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
20,838$1.66$34.6K378,318Mar 2, 2026Mar 5, 2026 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
6,317$1.75$11.0K399,156Feb 26, 2026Feb 27, 2026 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
289,000——389,000Feb 25, 2026Feb 27, 2026 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
16,473——405,473Feb 25, 2026Feb 27, 2026 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
27,425$2.64$72.3K100,000Dec 5, 2025Dec 8, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
14,387$2.90$41.7K127,425Dec 1, 2025Dec 3, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
6,175$3.35$20.7K141,812Sep 5, 2025Sep 9, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
3,138$3.36$10.6K147,987Sep 2, 2025Sep 4, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
6,057$3.94$23.9K151,125Jun 5, 2025Jun 9, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
3,255$3.63$11.8K157,182Jun 2, 2025Jun 3, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
13,827$4.55$62.9K160,437Mar 6, 2025Mar 10, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
9,024$4.58$41.3K174,264Mar 3, 2025Mar 4, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
13,538——183,288Feb 20, 2025Feb 24, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
97,500——169,750Feb 20, 2025Feb 24, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
2,500$7.52$18.8K72,250Jan 6, 2025Jan 8, 2025 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
19,268$8.32$160.3K72,250Dec 6, 2024Dec 10, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
9,419$8.97$84.5K91,518Dec 1, 2024Dec 3, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
2,466$7.39$18.2K100,937Sep 6, 2024Sep 10, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
1,222$7.27$8.9K103,403Sep 3, 2024Sep 5, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
2,387$6.71$16.0K104,625Jun 6, 2024Jun 12, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
1,300$6.53$8.5K107,012Jun 3, 2024Jun 4, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
12,577$6.61$83.1K108,312May 31, 2024Jun 4, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
3,315$8.05$26.7K120,889Mar 1, 2024Mar 5, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
75,000——119,760Feb 20, 2024Feb 22, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
4,444——124,204Feb 20, 2024Feb 22, 2024 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
3,427$7.45$25.5K44,760Dec 1, 2023Dec 5, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
20,000——48,187Oct 5, 2023Oct 6, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
1,157$11.52$13.3K28,187Sep 6, 2023Sep 6, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
500$11.78$5.9K29,344Sep 1, 2023Sep 6, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
1,078$11.84$12.8K29,844Jun 6, 2023Jun 8, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
SALE
General Counsel
577$11.24$6.5K30,922Jun 1, 2023Jun 5, 2023 ↗View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
20,000——31,499May 3, 2023May 4, 2023 ↗View →
Other insiders · HCAT
Loading peer insiders…
About this filer
CIK 0001975281
ROLE
General Counsel
PRIMARY
HCAT
COMPANIES
1
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001975281DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback